Colorcon Acquires BASF’s Kollicoat IR Coating Systems
Colorcon Acquired BASF’s Kollicoat IR Coating System product line, which includes currently customer business, and inventory.
On May 25, 2016 Colorcon announced that it has acquired BASF’s Kollicoat IR Coating Systems product line, including its current customer businessand inventory. This will extend Colorcon’s existing film coating product line. Final closure of the transaction is subject to review of the Brazilian competition authorities. After completion of the transaction, Colorcon will serve all Kollicoat IR Coating Systems customers.
Colorcon recently opened a film coating manufacturing facility in São Paulo State, Brazil. Construction on the facility is scheduled to complete in October 2016, with the production of commercial-scale product scheduled for January 2017, the company said. The facility will produce GMP film coating productions for the pharmaceutical and nutritional markets in South America.
Source: Colorcon
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
